Physician profile
Jesslyn Perry
NPI 1205860186
$15,390.53
in general payments reported to CMS, 2019-2025
60 companies · $2,291 in 2025
The $2,291 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,887 · 2020: $1,705 · 2021: $3,005 · 2022: $1,466 · 2023: $1,867 · 2024: $2,170 · 2025: $2,291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,327.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,130.94 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $1,589.95 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $1,444.56 | 2019-2025 | Ozempic, Rybelsus |
| Insulet Corporation | $1,243.20 | 2019-2024 | Omnipod |
| Abbvie INC. | $1,112.04 | 2019-2024 | |
| Pfizer INC. | $924.65 | 2019-2025 | |
| Lilly USA, LLC | $903.73 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Exact Sciences Corporation | $467.72 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Grifols USA, LLC | $431.26 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $405.37 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $403.97 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $396.32 | 2019-2024 | Jardiance |
| Gilead Sciences, INC. | $347.08 | 2019-2024 | |
| Amgen INC. | $337.25 | 2019-2025 | Krystexxa, Repatha |
| Astellas Pharma US INC | $308.74 | 2023-2025 | Veozah |
Show all 60 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesslyn Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.